Clinical Trials Browser

Phase 2 × Neurocytoma × CNS × Clear all

NCT02684058 2023-12-13

Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors

Phase 2 Completed

151 enrolled 45 charts 1 FDA

Astrocytoma, Ganglioneuroma, Glioblastoma, Glioma, Oligodendroglioma, Ganglioglioma, Neurocytoma

NCT00003458 2022-03-07

Antineoplaston Therapy in Treating Children With Brain Tumors

Phase 2 Completed

34 enrolled 6 charts

Astrocytoma, Craniopharyngioma, Glioblastoma, Oligodendroglioma, Neuroectodermal Tumors, Primitive, Ganglioglioma, Neurocytoma, Gliosarcoma

NCT00003457 2017-08-22

Antineoplaston Therapy in Treating Patients With Brain Tumors

Phase 2 Completed

40 enrolled 6 charts

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Neuroectodermal Tumors, Primitive, Neurocytoma